Đăng nhập/ Đăng ký

Nasdaq-listed Sonnet BioTherapeutics agrees to $888 million merger to become Hyperliquid Strategies, launch HYPE treasury

14/07 19:18
Tăng giá
Bearish

Tin tức xu hướng